Follow
Locatelli Franco
Locatelli Franco
University of Pavia, Ospedale Bambino Gesù, Roma, Policlinico San Matteo
Verified email at opbg.net
Title
Cited by
Cited by
Year
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, ...
The Lancet 371 (9624), 1579-1586, 2008
29512008
Outcome of cord-blood transplantation from related and unrelated donors
E Gluckman, V Rocha, A Boyer-Chammard, F Locatelli, W Arcese, ...
New England Journal of Medicine 337 (6), 373-381, 1997
16961997
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
V Rocha, J Cornish, EL Sievers, A Filipovich, F Locatelli, C Peters, ...
Blood, The Journal of the American Society of Hematology 97 (10), 2962-2971, 2001
10002001
Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome
F Locatelli, B Canaud, KU Eckardt, P Stenvinkel, C Wanner, C Zoccali
Nephrology Dialysis Transplantation 18 (7), 1272-1280, 2003
9752003
Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms
ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ...
Cancer research 67 (19), 9142-9149, 2007
9102007
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the …
V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ...
Blood, The Journal of the American Society of Hematology 115 (16), 3206-3214, 2010
8482010
Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a …
R Maccario, M Podestà, A Moretta, A Cometa, P Comoli, D Montagna, ...
Haematologica 90 (4), 516-525, 2005
8112005
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
S Giebel, F Locatelli, T Lamparelli, A Velardi, S Davies, G Frumento, ...
Blood 102 (3), 814-819, 2003
6822003
Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell …
LM Ball, ME Bernardo, H Roelofs, A Lankester, A Cometa, RM Egeler, ...
Blood, The Journal of the American Society of Hematology 110 (7), 2764-2767, 2007
6612007
Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial
C Pozzi, S Andrulli, L Del Vecchio, P Melis, GB Fogazzi, P Altieri, ...
Journal of the American Society of Nephrology 15 (1), 157-163, 2004
6092004
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
R Ciccocioppo, ME Bernardo, A Sgarella, R Maccario, MA Avanzini, ...
Gut 60 (6), 788-798, 2011
6062011
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases
CM Niemeyer, M Arico, G Basso, A Biondi, AC Rajnoldi, U Creutzig, ...
Blood, The Journal of the American Society of Hematology 89 (10), 3534-3543, 1997
5131997
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
RC Atkins, EM Briganti, JB Lewis, LG Hunsicker, G Braden, ...
American journal of kidney diseases 45 (2), 281-287, 2005
5062005
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy
T Berl, LG Hunsicker, JB Lewis, MA Pfeffer, JG Porush, JL Rouleau, ...
Annals of internal medicine 138 (7), 542-549, 2003
5042003
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
C Ponticelli, P Zucchelli, P Passerini, B Cesana, F Locatelli, S Pasquali, ...
Kidney international 48 (5), 1600-1604, 1995
5021995
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice
E Gluckman, V Rocha, W Arcese, G Michel, G Sanz, KW Chan, ...
Experimental hematology 32 (4), 397-407, 2004
4872004
Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ...
Journal of Clinical Oncology 34 (36), 4381-4389, 2016
4782016
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
F Locatelli, V Rocha, W Reed, F Bernaudin, M Ertem, S Grafakos, ...
Blood, The Journal of the American Society of Hematology 101 (6), 2137-2143, 2003
4752003
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
M Schrappe, MG Valsecchi, CR Bartram, A Schrauder, ...
Blood, The Journal of the American Society of Hematology 118 (8), 2077-2084, 2011
4602011
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
A Bertaina, P Merli, S Rutella, D Pagliara, ME Bernardo, R Masetti, ...
Blood, The Journal of the American Society of Hematology 124 (5), 822-826, 2014
4432014
The system can't perform the operation now. Try again later.
Articles 1–20